{
    "id": 6684,
    "fullName": "CDKN1A loss",
    "impact": "unknown",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "CDKN1A loss indicates loss of the CDKN1A gene, mRNA, and protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 1026,
        "geneSymbol": "CDKN1A",
        "terms": [
            "CDKN1A",
            "CAP20",
            "CDKN1",
            "CIP1",
            "MDA-6",
            "P21",
            "p21CIP1",
            "SDI1",
            "WAF1"
        ]
    },
    "variant": "loss",
    "createDate": "05/28/2015",
    "updateDate": "11/29/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 4552,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, AZD7762 enhanced sensitivity to Gemzar (gemcitabine) in bladder cancer cell lines harboring CDKN1A loss and TP53 loss, resulting in decreased cell growth in culture (PMID: 25349305).",
            "molecularProfile": {
                "id": 17584,
                "profileName": "CDKN1A loss TP53 loss"
            },
            "therapy": {
                "id": 1968,
                "therapyName": "AZD7762 + Gemcitabine",
                "synonyms": null
            },
            "indication": {
                "id": 11054,
                "name": "urinary bladder cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4471,
                    "pubMedId": 25349305,
                    "title": "Combined CDKN1A/TP53 mutation in bladder cancer is a therapeutic target.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25349305"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 4551,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, PF-00477736 enhanced sensitivity to Gemzar (gemcitabine) in bladder cancer cell lines harboring CDKN1A loss and TP53 loss, resulting in decreased tumor growth in xenograft models (PMID: 25349305).",
            "molecularProfile": {
                "id": 17584,
                "profileName": "CDKN1A loss TP53 loss"
            },
            "therapy": {
                "id": 3466,
                "therapyName": "Gemcitabine + PF-00477736",
                "synonyms": null
            },
            "indication": {
                "id": 11054,
                "name": "urinary bladder cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4471,
                    "pubMedId": 25349305,
                    "title": "Combined CDKN1A/TP53 mutation in bladder cancer is a therapeutic target.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25349305"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 6536,
            "profileName": "CDKN1A loss",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 17584,
            "profileName": "CDKN1A loss TP53 loss",
            "profileTreatmentApproaches": [
                {
                    "id": 7620,
                    "name": "AZD7762 + Gemcitabine",
                    "profileName": "CDKN1A loss TP53 loss"
                },
                {
                    "id": 7619,
                    "name": "Gemcitabine + PF-00477736",
                    "profileName": "CDKN1A loss TP53 loss"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}